學術研究成果/Publication
|
基本資料/Profiles
|
姓名/Name: |
林膺峻
|
性別/Gender: |
男
|
英文姓名/ English Name: |
Lin,Ying-Chun
|
英文縮寫/ Abbreviation: |
|
任職單位/ Affiliation: |
1.醫學院醫學系學士班放射腫瘤學科(助理教授) / Department of Radiation Oncology (Assistant Professor) 2.中國附醫放射腫瘤部粒子放射治療科(主治醫師) / (Attending Physician) 3.北港醫院放射腫瘤科(兼任醫師) / ()
|
Email: |
lyc12081028@gmail.com
|
研究專長/Fields of Specialty
|
1﹒ |
臨床腫瘤放射線治療(頭頸癌、肝癌)
|
2﹒ |
輻射生物學
|
3﹒ |
影像基因體學
|
|
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
|
SCI論文 |
涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、林膺峻(Lin,Ying-Chun)、梁基安(Ji-An Liang)、李佳瑾、簡君儒(Chien, Chun-Ru)*,Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors,Canadian Respiratory Journal,2024 Mar,2024():8889536-8889536
|
SCI論文 |
林膺峻(Lin,Ying-Chun)、(Jiamin Mo)、(Hanyan Zeng)、李元皓*,Radiation-induced Bystander Effects on Glioblastoma Tumor Cells via NMDA Receptor Signaling,RADIATION RESEARCH,2024 Jan,201():197-205
|
SCI論文 |
李佳瑾(Chia-Chin Li)、林膺峻(Lin,Ying-Chun)、梁基安(Ji-An Liang)、趙坤山(Kun-San Clifford Chao)、夏德椿(Te-Chun Hsia)、簡君儒(Chien, Chun-Ru)*,Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review,International Journal of Environmental Research and Public Health,2023 Mar,20():4727
|
SCI論文 |
(Chia-Chin Li)、(Chih-Yi Chen)、(Ying-Hsiang Chou)、(Chih-Jen Huang)、(Hsiu-Ying Ku)、林膺峻(Lin,Ying-Chun)、簡君儒(Chien, Chun-Ru)*,High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study,Discover Oncology,2022 Nov,13(1):130
|
Other論文 |
陳芮筠(Rui-Yun Chen)、梁基安(Ji-An Liang)、洪耀欽(Hung, Yao-Ching)、葉聯舜(Lian-Shung Yeh)、張維君(Wei-Chun Chang)、林武周(Wu-Chou Lin)、陳尚文(Chen, Shang-Wen)、張穎宜(Yin-Yi Chang)、林膺峻(Lin,Ying-Chun)*,Quantitative Differences in Levels of Immunohistochemical Biomarkers between Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix: Implications for Treatment Outcomes after Chemoradiotherapy,Journal of women's health and development,2022 Nov,5(3):271-281
|
SCI論文 |
許偉帆(Hsu, Wei-Fan)、許士超(Shih-Chao Hsu)、陳德鴻(Te-Hung Chen)、林建宏(Chien-Hung Lin)、林膺峻(Lin,Ying-Chun)、張裕煒(Yu-Wei Chang)、王鴻偉(Hung-Wei Wang)、廖裕民(Yu-Min Liao)、賴學洲(Hsueh-Chou Lai)、彭成元(Peng, Cheng-Yuan)*,Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy,Cancers,2022 Oct,14(20):5083
|
SCI論文 |
林亭君(Ting-Chun Lin)、黃繼賢(Huang Chi Hsien)、連銘渝(Ming-Yu Lien)、鄭富銘(Fu-Ming Cheng)、李開群(Chih-Yuan Lin)、林膺峻(Lin,Ying-Chun)、梁基安(Ji-An Liang)、王帝皓(Ti-Hao Wang)*,Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study,TECHNOLOGY IN CANCER RESEARCH & TREATMENT,2022 Jun,21():1-11
|
SCI論文 |
許偉帆(Hsu, Wei-Fan)、張凱智(CHANG, KAI-CHIH)、陳德鴻(Te-Hung Chen)、林建宏(Chien-Hung Lin)、林膺峻(Lin,Ying-Chun)、蔡明宏(Ming-Hung Tsai)、陳旆聿(Pei-Yu Chen)、王鴻偉(Hung-Wei Wang)、朱家聲(Chia-Sheng Chu)、彭成元(Cheng-Yuan Peng)*,Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma,MEDICINE,2021 Aug,100(33):e27000
|
SCI論文 |
李芃逸(Peng-Yi Lee)、賴榮年(Jung-Nien Lai)、陳尚文(Shang-Wen Chen)、林膺峻(Lin,Ying-Chun)、邱侶婷、魏玉亭(WEI YU-TING)*,Radiotherapy combined with chemotherapy increases the risk of herpes zoster in patients with gynecological cancers: a nationwide cohort study,Journal of Gynecologic Oncology,2021 Jan,32(1):e13
|
SCI論文 |
林膺峻(Yin-Jun Lin)、陳郁佳(Yu-Chia Chen)、陳芮筠(Rui-Yun Chen)、黃義軒(Huang, Yi-Xuan)、塗翔鈞(TU SIANG-JYUN)、梁基安(Ji-An Liang)、洪耀欽(Yao-Ching Hung)、葉聯舜(Lian-Shung Yeh)、張維君(Wei-Chun Chang)、林武周(Wu-Chou Lin)、張穎宜(Yin-Yi Chang)、陳尚文(Shang-Wen Chen)*、張建國(Jan-Gowth Chang)*,Genomic Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2020 Jun,21():4117
|
SCI論文 |
李欣倫(Hsin-Lun Lee)、蔡若婷(Jo-Ting Tsai)、陳俊佑(Chun-You Chen)、林膺峻(Yin-Jun Lin)、何俊敏(Chin-Beng Ho)、丁禮莉(Lai-Lei Ting)、郭嘉駿(Chia-Chun Kuo)、賴宜君(I-Chun Lai)、林俊宇(Chun-Yu Lin)、唐瑞祥(Jui-Hsiang Tang)、黃昱閔(Yu-Min Huang)、高偉育(Wei-Yu Kao)、鄭勝偉(Sheng-Wei Cheng)、沈家寧(Chia-Ning Shen)*、陳尚文(Shang-Wen Chen)*、邱仲峰(Jeng-Fong Chiou)*,Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolizati,Therapeutic Advances in Medical Oncology,2019 Dec,11():1-13
|
SCI論文 |
林膺峻(Yin-Jun Lin)、陳芮筠(Rui-Yun Chen)、梁基安(Ji-An Liang)、洪耀欽(Yao-Ching Hung)、葉聯舜(Lian-Shung Yeh)、張維君(Wei-Chun Chang)、林武周(Wu-Chou Lin)、張穎宜(Yin-Yi Chang)、陳尚文(Shang-Wen Chen)*,Immunohistochemical Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy,ANTICANCER RESEARCH,2019 Jun,39(6):3231-3240
|
SCI論文 |
陳芮筠(Chen Rui-Yun)、林膺峻(Ying-Chun Lin)、(Wei-Chih Shen)、謝德鈞(Hsieh, Te-Chun)、顏國揚(Yen, Kuo-Yang)、陳尚文(Chen, Shang-Wen)*、高嘉鴻(Kao, Chia-Hung)*,Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in 18F-FDG PET in Squamous Cell Carcinoma of the Head and Neck,Scientific Reports,2018 Jan,8():105
|
SCI論文 |
陳芮筠(Chen Rui-Yun)、林膺峻(Ying-Chun Lin)、陳尚文(Chen, Shang-Wen)*、林智一(Lin, Tze-Yi)、謝德鈞(Hsieh, Te-Chun)、顏國揚(Yen, Kuo-Yang)、梁基安(Liang, Ji-An)、楊世能(Yang, Shih-Neng)、王耀慶(Wang, Yao-Ching)、陳雅惠(Chen, Ya-Huey)、姜淑芬(Shu-Fen Chiang)、高嘉鴻(Kao, Chia-Hung)*,Immunohistochemical biomarkers and volumetric parameters for predicting radiotherapy-based outcomes in patients with p16-negative pharyngeal cancer,Oncotarget,2017 Aug,8(42):72342-72351
|
SCI論文 |
林膺峻(Ying-Chun Lin)、陳芮筠(Chen Rui-Yun)、陳尚文(Shang-Wen Chen)*、謝德鈞(Te-Chun Hsieh)、顏國揚(Kuo-Yang Yen)、梁基安(Ji-An Liang)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、陳雅惠(Ya-Huey Chen)、(Chow, N.-H.)、高嘉鴻(Chia-Hung Kao)*,Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes,CLINICAL OTOLARYNGOLOGY,2017 Jun,42(3):608-619
|
SCI論文 |
陳尚文(Shang-Wen Chen)、沈偉誌(Wei-Chih Shen)、林膺峻(Ying-Chun Lin)、陳芮筠(Chen Rui-Yun)、謝德鈞(Te-Chun Hsieh)、顏國揚(Kuo-Yang Yen)、高嘉鴻(Chia-Hung Kao)*,Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes,EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,2017 Apr,44(4):567-580
|
SCI論文 |
李芃逸(Peng-Yi Lee)、林智遠(Chih-Yuan Lin)、陳尚文(Shang-Wen Chen)、簡君儒(Chun-Ru Chien)、朱俊男(Chu, Chin-Nan)、許琇婷(Hsiu-Ting Hsu)、梁基安(Ji-An Liang)、林膺峻(Ying-Chun Lin)、蕭安成(An-Cheng Shiau)*,A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy,Radiation Oncology,2017 Mar,12(55):1-9
|
SCI論文 |
陳尚文(Shang-Wen Chen)、林膺峻(Ying-Chun Lin)、陳芮筠(Chen Rui-Yun)、謝德鈞(Te-Chun Hsieh)、顏國揚(Kuo-Yang Yen)、梁基安(Ji-An Liang)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、陳雅惠(Ya-Huey Chen)、周楠華(Nan-Haw Chow)、高嘉鴻(Chia-Hung Kao)*,Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer,EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,2016 Dec,43(13):2343-2352
|
SCI論文 |
簡君儒(Chun-Ru Chien)*、陳自諒(William Tzu-Liang Chen)、王輝明(Hwei-Ming Wang)、柯道維(TAO-WEI KE)、江驊哲(Hua-Che Chiang)、張伸吉(Sheng-Chi Chang)、黃郁純(YU-CHUEN HUANG)、林哲弘(Che-Hung Lin)、黃駿麟、林膺峻(Ying-Chun Lin)、陳宗偉(Tsung-Wei Chen)、李佳瑾、趙坤山(Kun-San Chao),A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer,ANTICANCER RESEARCH,2016 Nov,36(11):6155-6160
|
Other論文 |
李芃逸(Peng-Yi Lee)、簡君儒(Chien, Chun-Ru)、陳自諒(Chen, William Tzu-Liang)、柯道維(TAO-WEI KE)、郭于誠(Yu-Cheng, Kuo)、張伸吉(Sheng-Chi Chang)、林膺峻(Ying-Chun Lin),Treatment outcomes of neoadjuvant CCRT in patients with locally advanced rectal cancer- A single institutional report,放射治療與腫瘤學,2016 Jun,23(2):85-97
|
SCI論文 |
林膺峻(Shih-Chieh Lin)、陳尚文(Shang-Wen Chen)、謝德鈞(Te-Chun Hsieh)、顏國揚(Kuo-Yang Yen)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、高嘉鴻(Chia-Hung Kao)*,Risk Stratification of Metastatic Neck Nodes by CT and PET in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy.,JOURNAL OF NUCLEAR MEDICINE,2015 Feb,56(2):183-189
|
SCI論文 |
林士捷(Shih-Chieh Lin)、廖志穎(Chih-Ying LIAO)、高嘉鴻(Chia-Hung Kao)*、顏國揚(Kuo-Yang Yen)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、梁基安(Ji-An Liang)、陳尚文(Shang-Wen Chen)*,Pretreatment Maximal Standardized Uptake Value of the Primary Tumor Predicts Outcome to Radiotherapy in Patients with Pharyngeal Cancer,JOURNAL OF RADIATION RESEARCH,2012 Jun,53(3):462-468
|
SCI論文 |
高嘉鴻(Chia-Hung Kao)*、林士捷(Shih-Chieh Lin)、謝德鈞(Te-Chun Hsieh)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、梁基安(Ji-An Liang)、花俊宏(Chun-Hung Hua)、陳尚文(Shang-Wen Chen)*,Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy,EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,2012 Apr,39():1297-1305
|
Other論文 |
林士捷(Shih-Chieh Lin)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、梁基安(Ji-An Liang)、郭于誠(Yu-Cheng, Kuo)、林芳仁(Fang-Jen Lin)、陳尚文(Shang-Wen Chen)*,Clinical Implications of Tumor Volume in Patients with the Base of Tongue Cancer Treated with Definitive Intensity-Modulated Radiotherapy Technique,放射治療與腫瘤學,2011 Oct,18(3):193-204
|
|
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
|
1﹒ |
Effectiveness of stereotactic body radiotherapy divided in 5 to 6 fractions for patients with hepatocellular carcinoma,第二十七屆台灣癌症聯合學術年會,臺大醫院國際會議中心,2023.5.6 ~ 2023.5.7,
|
2﹒ |
Modified albumin–bilirubin model for stratifying survival in patients with hepatocellular carcinoma receiving anticancer therapy,2022TDDW台灣消化醫學週,台大國際會議中心,2022.9.24 ~ 2022.9.25,
|
3﹒ |
Modified cutoffs for ALBI grade for patients with early, intermediate, or advanced hepatocellular carcinoma,2022 Asian Pacific Association for the Study of the Liver Single Topic Conference on Hepatocellular Carcinoma,台大醫院國際會議中心,2022.6.23 ~ 2022.6.25,
|
4﹒ |
Comparison of ten liver functional reserve models for overall survival in patients with intermediate-stage hepatocellular carcinoma and different stratification,中華民國一一O年台灣消化系聯合學術演講年會,中國醫藥大學英才校區,2021.3.27 ~ 2021.3.28,
|
5﹒ |
,The 6th Taiwan-Japan Radiation Oncology Symposium ( 2018 年第六屆台灣-日本放射線腫瘤研討 ),台中市豐邑市政都心廣場 3F 國際會議廳,2018.5.19 ~ 2018.5.19,Biological Implications of 18F-FDG-PET Derived Radiomics in Pharyngeal Cancer Patients Treated with Definitive chemoradiotherapy
|
6﹒ |
Molecular Mechanism of Image-based Intratumoral heterogenety in Head and Neck Squamaous Cell Carcinoma,台灣放射腫瘤學會TASTRO 2016年度學術研討會,中國醫藥大學,2016.12.3 ~ 2016.12.3,
|
7﹒ |
,The 3rd Japan-Taiwan Radiation Oncology Symposium,yamanashi,2015.6.27 ~ 2015.6.28,Preliminary Results of Neoadjuvant CCRT in Locally Advanced Rectal Cancer in CMUH
|
8﹒ |
TREATMENT OUTCOMES OF NEOADJUVANT CCRT IN PATIENTSWITH LOCALLY ADVANCED RECTAL CANCER,2015 The 20th Taiwan Joint Cancer Conference,Taipei, Taiwan,2015.5.2 ~ 2015.5.3,
|
9﹒ |
Pretreatment Maximal Standardized Uptake Value of the Primary Tumor Predicts Short-Term Outcome to Intensity-Modulated Radiotherapy in Patients with Pharyngeal Cancer,2011 The 16th Taiwan Joint Cancer Conference,三軍總醫院,2011.4.30 ~ 2011.5.1,
|
10﹒ |
Clinical Implications of Tumor Volume in Patients with the Base of Tongue Cancer Treated with Definitive Intensity-Modulated Radiotherapy Technique,2010 The 15 th Taiwan Joint Cancer Conference,三軍總醫院,2010.5.1 ~ 2010.5.2,
|
|
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
|
1﹒ |
個別型,DMR-113-052,林膺峻(Lin,Ying-Chun),陳雅惠(Ya-Huey Chen),附醫院內計畫,解析頭頸癌中MCL-1所調控的代謝重整及PD-L1的表現與其在臨床的應用,$200000,2023.8.1 ~ 2024.7.31
|
2﹒ |
個別型,CMU111-N-07,李元皓(Lee, Yuan-Hao),林膺峻(Lin,Ying-Chun),本校(含附醫),突觸傳遞扮演於放射治療之旁觀者效應中的角色,$240000,2022.10.3 ~ 2023.7.31
|
3﹒ |
個別型,MOST 108-2314-B-039-008-MY3,林膺峻(Lin,Ying-Chun),陳芮筠(Rui-Yun Chen),國科會,解讀癌症正子影像紋理特徵的生物機轉以邁向癌症的精準治療,$1200000,2020.8.1 ~ 2021.7.31
|
4﹒ |
臨床試驗與研究計畫,CMUH108-REC2-038,林膺峻(Lin,Ying-Chun),陳尚文(Shang-Wen Chen)、彭成元(Cheng-Yuan Peng)、賴學洲(Hsueh-Chou Lai)、許偉帆(Hsu, Wei-Fan)、蕭望德(Won-Der Shau)、陳德鴻(Te-Hung Chen),,比較肝動脈化學栓塞療法後未達完全緩解時合併立體定位燒灼性放射治療或繼續肝動脈化學栓塞療法的臨床隨機對照試驗,$400000,2020.1.1 ~ 2020.12.31
|
5﹒ |
個別型,DMR-109-053,陳尚文(Shang-Wen Chen),林膺峻(Yin-Jun Lin)、陳芮筠(Rui-Yun Chen),附醫院內計畫,子宮頸癌正子攝影檢查紋理分析之不均質性與基因表現差異的關聯性,$500000,2019.8.1 ~ 2020.7.31
|
6﹒ |
個別型,MOST 108-2314-B-039-008-MY3,林膺峻(Yin-Jun Lin),陳芮筠(Rui-Yun Chen),國科會,解讀癌症正子影像紋理特徵的生物機轉以邁向癌症的精準治療,$1200000,2019.8.1 ~ 2020.7.31
|
7﹒ |
臨床試驗與研究計畫,CMUH108-REC2-038,林膺峻(Yin-Jun Lin),陳尚文(Shang-Wen Chen)、彭成元(Cheng-Yuan Peng)、賴學洲(Hsueh-Chou Lai)、許偉帆(Wei-Fan Hsu)、蕭望德(Won-Der Shau)、陳德鴻(Te-Hung Chen),,比較肝動脈化學栓塞療法後未達完全緩解時合併立體定位燒灼性放射治療或繼續肝動脈化學栓塞療法的臨床隨機對照試驗,$400000,2019.1.1 ~ 2019.12.31
|
8﹒ |
個別型,MOST 106-2314-B-039-006,林膺峻(Ying-Chun Lin),陳雅惠(Chen, Ya-Huey),國科會,探討咽喉癌中訊息傳遞之調控路徑與正子影像之紋理分析的相關性,$1128000,2017.8.1 ~ 2018.7.31
|
9﹒ |
個別型,MOST 106-2314-B-039-006-,林膺峻(Ying-Chun Lin),陳雅惠(Chen, Ya-Huey),國科會,探討咽喉癌中訊息傳遞之調控路徑與正子影像之紋理分析的相關性,$1128000,2017.8.1 ~ 2018.7.31
|
10﹒ |
臨床試驗與研究計畫,CMUH105-REC2-143,葉士芃(Yeh, Su-Peng),楊世能(Yang, Shih-Neng)、王耀慶(Wang, Yao-Ching)、林膺峻(Ying-Chun Lin)、謝清昀(Ching-Yun Hsieh)、連銘渝(Ming-Yu Lein),附醫廠商計畫,一項隨機分配、雙盲、第三期試驗,比較Avelumab併用標準照護化學放射線治療(Cisplatin搭配主程性放射線治療)與標準照護化學放射線治療,用於第一線治療局部晚期鱗狀上皮細胞頭頸癌的患者,$5885400,2017.1.1 ~ 2017.12.31
|
11﹒ |
臨床試驗與研究計畫,CMUH106-REC1-050,趙坤山(Chao, Kun-San),蔡銘修(Tsai, Ming-Hsui)、花俊宏(Chun-Hung Hua)、詹日全(Jih-Chuan Jan)、林日新(Ryh-Hsin Lin)、楊世能(Yang, Shih-Neng)、王耀慶(Wang, Yao-Ching)、林膺峻(Ying-Chun Lin)、王帝皓(Ti-Hao Wang)、謝清昀(Ching-Yun Hsieh)、連銘渝(Ming-Yu Lein),附醫廠商計畫,一項針對頭頸癌病患,使用PEP503(放射線治療提升劑),合併同步化學治療藥物及放射線治療的第1b/2期臨床試驗,$13415282,2017.1.1 ~ 2017.12.31
|
12﹒ |
臨床試驗與研究計畫,CMUH104-REC1-097,朱俊男(Chu, Chin-Nan),王耀慶(Wang, Yao-Ching)、林膺峻(Ying-Chun Lin)、陳尚文(Chen, Shang-Wen)、劉良智(Liu, Liang-Chih)、陳芝蓉(Chih-Jung Chen),附醫廠商計畫,使用口服 JBM-TC4 預防乳癌病患因放射線治療引發急性皮膚炎之臨床二期試驗,$2022239,2017.1.1 ~ 2017.12.31
|
13﹒ |
個別型,MOST 105-2314-B-039-023,林膺峻(Ying-Chun Lin),陳雅惠(Ya-Huey Chen),國科會,研究口咽與下咽癌中基因表現差異在正子檢查之參數不均質,$850000,2016.8.1 ~ 2017.7.31
|
14﹒ |
個別型,DMR-106-062,李佳容(Chia-jung Lee),林智遠(Chih-Yuan Lin)、蕭安成(An-Cheng Shiau)、林膺峻(Ying-Chun Lin),附醫院內計畫,建立放射治療影像導引系統的品質保證作業程序並以此系統分析早期乳癌術後治療原腫瘤位置的不確定性,$200000,2016.8.1 ~ 2017.7.31
|
15﹒ |
個別型,MOST 105-2314-B-039-023-,林膺峻(Ying-Chun Lin),陳雅惠(Ya-Huey Chen),國科會,研究口咽與下咽癌中基因表現差異在正子檢查之參數不均質性的關聯性,$850000,2016.8.1 ~ 2017.7.31
|
16﹒ |
個別型,DMR-106-061,林膺峻(Ying-Chun Lin),陳尚文(Shang-Wen Chen),附醫院內計畫,研究口咽與下咽癌中基因表現差異在正子檢查之參數不均質性的關聯性,$420500,2016.8.1 ~ 2017.7.31
|
17﹒ |
臨床試驗與研究計畫,CMUH104-REC1-097,朱俊男(Chu, Chin-Nan),王耀慶(Yao-Ching Wang)、林膺峻(Ying-Chun Lin)、陳尚文(Shang-Wen Chen)、劉良智(Liu, Liang-Chih)、陳芝蓉(Chih-Jung Chen),附醫廠商計畫,使用口服 JBM-TC4 預防乳癌病患因放射線治療引發急性皮膚炎之臨床二期試驗,$1056300,2016.1.1 ~ 2016.12.31
|
18﹒ |
個別型,DMR-104-041,林膺峻(Shih-Chieh Lin),陳尚文(Shang-Wen Chen)、高嘉鴻(Chia-Hung Kao)、陳芮筠(Chen Rui-Yun),附醫院內計畫,口咽及下咽癌病人之腫瘤生物標記與正子攝影檢查的相關性及治療預後之研究,$200000,2014.8.1 ~ 2015.7.31
|
|